📰 Nasdaq Fdmt News
Page 4 - Nasdaq Fdmt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Fdmt. Real-time updates on events, politics, business and more.
August 2, 2023
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have received an average rating of “Moderate Buy” from the six ratings firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The […]
August 1, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) saw a significant decline in short interest in July. As of July 15th, there was short interest totalling 3,110,000 shares, a decline of 11.4% from the June 30th total of 3,510,000 shares. Based on an average daily volume of 589,600 shares, the days-to-cover ratio is currently […]
July 29, 2023
Dose response demonstrated in favor of highest tested dose of 3E10 vg/eye, including 100% reduction in supplemental anti-VEGF injections (4 of 4 evaluable...
June 14, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s stock price dropped 5.2% during trading on Wednesday . The stock traded as low as $21.99 and last traded at $22.06. Approximately 128,644 shares were traded during trading, a decline of 73% from the average daily volume of 480,035 shares. The stock had previously closed at $23.26. […]
June 10, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) shares traded up 7.5% on Friday after Bank of America raised their price target on the stock from $28.00 to $33.00. The stock traded as high as $21.29 and last traded at $20.99. 73,528 shares were traded during trading, a decline of 85% from the average session […]
June 9, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s share price was up 7.5% on Friday after Bank of America raised their price target on the stock from $28.00 to $33.00. The stock traded as high as $21.29 and last traded at $20.99. Approximately 73,528 shares changed hands during mid-day trading, a decline of 85% from […]
June 8, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s share price gapped up prior to trading on Thursday after Bank of America raised their price target on the stock from $28.00 to $33.00. The stock had previously closed at $18.27, but opened at $20.85. 4D Molecular Therapeutics shares last traded at $20.23, with a volume of […]
June 7, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) insider Scott Bizily sold 2,247 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $18.31, for a total value of $41,142.57. Following the completion of the sale, the insider now owns 1,737 shares […]
June 7, 2023
Reported data from cohort 1 (n=3, 1E15 vg dose) of cystic fibrosis modulator treatment ineligible/intolerant participants with 9-12 months follow-up ...
May 26, 2023
Opaleye Management Inc. decreased its position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) by 5.9% during the 4th quarter, Holdings Channel reports. The fund owned 330,000 shares of the company’s stock after selling 20,700 shares during the quarter. 4D Molecular Therapeutics makes up 2.5% of Opaleye Management Inc.’s portfolio, making the stock its […]